The genetics of transitional cell carcinoma: progress and potential clinical application
- 1 September 1999
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 84 (4) , 412-427
- https://doi.org/10.1046/j.1464-410x.1999.00217.x
Abstract
No abstract availableThis publication has 87 references indexed in Scilit:
- Mutation of the 9q34 gene TSC1 in sporadic bladder cancerOncogene, 1999
- Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31Oncogene, 1999
- Chromosomal aberrations associated with invasion in papillary superficial bladder cancerThe Journal of Pathology, 1998
- Structure and Methylation-Based Silencing of a Gene (DBCCR1) within a Candidate Bladder Cancer Tumor Suppressor Region at 9q32–q33Genomics, 1998
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasiaOncogene, 1997
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- Cancer Cell CyclesScience, 1996
- Oncogene Amplification in Urothelial Cancers With p53 Gene Mutation or MDM2 AmplificationJNCI Journal of the National Cancer Institute, 1994
- Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assayHuman Molecular Genetics, 1993